They started dosing 2/3 so they should see results for first patients by now...will be interesting for the next 30 days to pick up clues.<<
I'll take the other side of that speculation:
2016 ASCO key dates
It's fairly unusual for interim Phase 1 data to be presented, anyway. Though maybe less so the last few years. Still, I don't see how they make the deadline. Even a late breaker seems highly unlikely to me. I think ASH is more likely. It's possible they could present something before then at a relatively minor conference, but I wouldn't bank on that, either.
Edit: Abstract titles come out 4/20.
Regards, RockRat
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM